Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
107.50    -1.50 (-1.38%)
Bid:
105.00
Ask:
107.00
Spread: 2.00 (1.905%)
Market Cap: £105.94m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Directorate Change

26 Jan 2016 07:04

RNS Number : 9247M
Eurocell plc
26 January 2016
 

 

 

Eurocell plc

Directorate Change

 

 

Eurocell plc (LSE:ECEL), a market leading, vertically integrated UK manufacturer and distributor of innovative window, door and roofline PVC products, today announces that Patrick Bateman (63) has advised the board of his decision to retire from his role as Chief Executive and to step down from the board and leave the Company on 30 June 2016. The Company is also pleased to announce the appointment of Mark Kelly (55), as its next Chief Executive. 

 

Mark is currently Chief Executive of Grafton Merchanting GB, a subsidiary of Grafton Group plc, a position he has held since 2012. He joined Grafton from BDR Thermea where he was CEO in the UK. Prior to this, Mark held a range of senior positions at IMI, Novar and Mars UK. This included experience of the uPVC windows and doors industry when he worked at Caradon-owned Celuform and DuraflexIt is anticipated that Mark will join Eurocell, full time, on March 29th this year and formally take up his new role as Chief Executive on 1st July 2016, allowing a customary handover period with Patrick before his well-earned retirement.

 

Bob Lawson, Eurocell Chairman, commented:

 

"We are delighted that someone of Mark's calibre will be joining Eurocell. He is an experienced Chief Executive with a deep and broad understanding of the construction products sector from a manufacturing and distribution perspective. He has a proven ability to deliver revenue and profit growth, both organically and through acquisition, which will be invaluable as Eurocell continues its exciting development.

 

"Under Patrick's strong leadership, Eurocell has developed into one of the leading players in its market and he was instrumental in the company's successful IPO. When he retires from the company, he will leave a strong management team and an excellent business with a clear strategy for delivering sustainable future growth."

 

No further information is required to be disclosed pursuant to LR 9.6.13R.

 

Enquiries

 

Teneo Strategy (Financial PR)

Ben Foster

 

+44 20 3603 5221

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABAMFTMBBTBJF
Date   Source Headline
18th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20261:49 pmRNSResult of AGM
14th May 20267:00 amRNSTrading Update
1st May 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSLeadership Update - CFO Appointment
15th Apr 20267:00 amRNSPublication of 2025 Annual Report & Notice of AGM
23rd Mar 202610:15 amRNSDirector/PDMR Shareholding
19th Mar 202610:30 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2025
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
17th Feb 20267:00 amRNSTransaction in Own Shares - Buyback Complete
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20261:00 pmRNSDirectorate changes
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSDirector/PDMR Shareholding
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSYear End Trading Update
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:00 pmRNSPurchase of Shares via Employee Benefit Trust
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.